Perceived HBV ‐Related Stigma Is Associated With Lower Antiviral Medication Adherence in Patients With Chronic Hepatitis B
Journal of Viral Hepatitis · 2025
DOI: 10.1111/jvh.70010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2025. Verfasst von Hee-Soon Juon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Antiviral Agents, Hepatitis B, Chronic, Social Stigma, Medication Adherence. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Medication nonadherence among patients with chronic hepatitis B (CHB) can lead to severe liver disease progression, including liver cirrhosis and hepatocellular carcinoma (HCC). Yet the factors that influence adherence in high‐risk groups, like Korean Americans, remain unclear. Thus, this study explored the psychosocial and clinical factors affecting medication adherence in CHB patients. A cohort of 365 Korean American patients with CHB from two clinics in Philadelphia and Los Angeles was studied. The 8‐item Morisky Medication Adherence Scale (MMAS‐8) gauged their adherence to antiviral medication. Using descriptive and multivariable logistic regression analyses, we identified factors associated with MMAS‐8 scores. Of the participants, 78% were undergoing antiviral therapy, with over two‐thirds (69%) reporting medium to high adherence levels. The multivariable logistic regression analysis revealed that age, knowledge of sequalae of CHB, perceived HBV stigma and possession of pharmacy plan were associated with medication adherence. Older participants had higher medication adherence than younger. High knowledge of sequalae of CHB and low perceived HBV stigma were associated with higher medication adherence. Having pharmacy plans was also associated with higher medication adherence to antiviral therapy. These findings highlight the critical role of person‐related factors (e.g., knowledge and stigma) and healthcare factors in medication adherence. Future research should focus on developing targeted educational interventions focusing on personal factors to improve medication adherence among Korean American patients with CHB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- Liver Disease Prevention Center, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
- Asian Pacific Liver Center, Coalition of Inclusive Medicine, Los Angeles, California, USA.
- Dornsife School of Public Health, Drexel University, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Hee-Soon Juon
Förderung
- NIDDK NIH HHS
- NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health
Zitieren
APA
Juon, H. S., Yang, D., Fang, C. X., Hann, H. W., Bae, H., Chang, M., & Klassen, A. C. (2025). Perceived HBV ‐Related Stigma Is Associated With Lower Antiviral Medication Adherence in Patients With Chronic Hepatitis B. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.70010
Vancouver
Juon HS, Yang D, Fang CX, Hann HW, Bae H, Chang M, et al. Perceived HBV ‐Related Stigma Is Associated With Lower Antiviral Medication Adherence in Patients With Chronic Hepatitis B. Journal of Viral Hepatitis. 2025. doi:10.1111/jvh.70010
BibTeX
@article{Juon2025,
author = {Juon, Hee-Soon and Yang, Daniel and Fang, Cindy Xin and Hann, Hie-Won and Bae, Ho and Chang, Mimi and Klassen, Ann C},
title = {Perceived HBV ‐Related Stigma Is Associated With Lower Antiviral Medication Adherence in Patients With Chronic Hepatitis B},
journal = {Journal of Viral Hepatitis},
year = {2025},
doi = {10.1111/jvh.70010}
}
EUVIMED